Smoking and multiple sclerosis: An updated meta- analysis

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Handel, Adam E ^a,b   Williamson, Alexander J ^b   Disanto, Giulio ^a,b   Dobson, Ruth ^c   Giovannoni, Gavin ^c   Ramagopalan, Sreeram V ^a,b,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CIGARETTE SMOKING; DISEASE PREDISPOSITION; HUMAN; MULTIPLE SCLEROSIS; RISK FACTOR; SEX RATIO; SMOKING HABIT; DISEASE COURSE; META ANALYSIS; SMOKING;

DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; HUMANS; MULTIPLE SCLEROSIS; RISK FACTORS; SMOKING;

EID: 79251559434     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016149     Document Type: Article

References (52)

1. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343: 938-952.
2. Handel AE, Giovannoni G, Ebers GC, Ramagopalan SV (2010) Environmental factors and their timing in adult-onset multiple sclerosis. Nat Rev Neurol 6: 156-166.
3. Handel AE, Handunnetthi L, Giovannoni G, Ebers GC, Ramagopalan SV (2010) Genetic and environmental factors and the distribution of multiple sclerosis in Europe. Eur J Neurol.
4. Simon KC, van der Mei IA, Munger KL, Ponsonby A, Dickinson J, et al. (2010) Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1 1501 on multiple sclerosis risk. Neurology 74: 1365-1371.
5. Ramagopalan SV, Maugeri NJ, Handunnetthi L, Lincoln MR, Orton SM, et al. (2009) Expression of the multiple sclerosis-associated MHC class II Allele HLADRB 1 1501 is regulated by vitamin D. PLoS Genet 5: e1000369.
6. Thorogood M, Hannaford PC (1998) The influence of oral contraceptives on the risk of multiple sclerosis. Br J Obstet Gynaecol 105: 1296-1299.
7. Antonovsky A, Leibowitz U, Smith HA, Medalie JM, Balogh M, et al. (1965) Epidemiologic Study of Multiple Sclerosis in Israel. I. An Overall Review of Methods and Findings. Arch Neurol 13: 183-193.
8. Carlens C, Hergens MP, Grunewald J, Ekbom A, Eklund A, et al. (2010) Smoking, use of moist snuff, and risk of chronic inflammatory diseases. Am J Respir Crit Care Med 181: 1217-1222.
9. Ghadirian P, Dadgostar B, Azani R, Maisonneuve P (2001) A case-control study of the association between socio-demographic, lifestyle and medical history factors and multiple sclerosis. Can J Public Health 92: 281-285.
10. Hedstrom AK, Baarnhielm M, Olsson T, Alfredsson L (2009) Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis. Neurology 73: 696-701.
11. Hernan MA, Olek MJ, Ascherio A (2001) Cigarette smoking and incidence of multiple sclerosis. Am J Epidemiol 154: 69-74.
12. Hernan MA, Jick SS, Logroscino G, Olek MJ, Ascherio A, et al. (2005) Cigarette smoking and the progression of multiple sclerosis. Brain 128: 1461-1465.
13. Jafari N, Hoppenbrouwers IA, Hop WC, Breteler MM, Hintzen RQ (2009) Cigarette smoking and risk of MS in multiplex families. Mult Scler 15: 1363-1367.
14. Riise T, Nortvedt MW, Ascherio A (2003) Smoking is a risk factor for multiple sclerosis. Neurology 61: 1122-1124.
15. Silva KR, Alvarenga RM, Fernandez YFO, Alvarenga H, Thuler LC (2009) Potential risk factors for multiple sclerosis in Rio de Janeiro: a case-control study. Arq Neuropsiquiatr 67: 229-234.
16. Pekmezovic T, Drulovic J, Milenkovic M, Jarebinski M, Stojsavljevic N, et al. (2006) Lifestyle factors and multiple sclerosis: A case-control study in Belgrade. Neuroepidemiology 27: 212-216.
17. Rodriguez Regal A, del Campo Amigo M, Paz-Esquete J, Martinez Feijoo A, Cebrian E, et al. (2009) [A case-control study of the influence of the smoking behaviour in multiple sclerosis]. Neurologia 24: 177-180.
18. Russo C, Morabito F, Luise F, Piromalli A, Battaglia L, et al. (2008) Hyperhomocysteinemia is associated with cognitive impairment in multiple sclerosis. J Neurol 255: 64-69.
19. Fowles J, Christophersen A, Fernando D, Lea R, Woodward A, et al. (2006) Secondhand tobacco smoke exposure in New Zealand bars: results prior to implementation of the bar smoking ban. N Z Med J 119: U1931.
20. Koch-Henriksen N, Sorensen PS (2010) The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 9: 520-532.
21. Hawkes CH (2007) Smoking is a risk factor for multiple sclerosis: a metanalysis. Mult Scler 13: 610-615.
22. De Jager PL, Chibnik LB, Cui J, Reischl J, Lehr S, et al. (2009) Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score. Lancet Neurol 8: 1111-1119.
23. Healy BC, Ali EN, Guttmann CR, Chitnis T, Glanz BI, et al. (2009) Smoking and disease progression in multiple sclerosis. Arch Neurol 66: 858-864.
24. Koch M, van Harten A, Uyttenboogaart M, De Keyser J (2007) Cigarette smoking and progression in multiple sclerosis. Neurology 69: 1515-1520.
25. Sundstrom P, Nystrom L (2008) Smoking worsens the prognosis in multiple sclerosis. Mult Scler 14: 1031-1035.
26. Pittas F, Ponsonby AL, van der Mei IA, Taylor BV, Blizzard L, et al. (2009) Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis. J Neurol.
27. Clayton D, Hills M (1993) Statistical models in epidemiology: Oxford University Press. viii, 367 p.
28. Bland JM, Altman DG (2000) Statistics notes. The odds ratio. BMJ 320: 1468.
29. Dahl J, Myhr KM, Daltveit AK, Skjaerven R, Gilhus NE (2007) Is smoking an extra hazard in pregnant MS women? Findings from a population-based registry in Norway. Eur J Neurol 14: 1113-1117.
30. Frutos Alegria MT, Beltran-Blasco I, Quilez-Iborra C, Molto-Jorda J, Diaz- Marin C, et al. (2002) [The epidemiology of multiples sclerosis in Alcoi. Analytical data]. Rev Neurol 34: 813-816.
31. Frutos-Alegria MT, Beltran-Blasco I, Quilez-Iborra C, Molto-Jorda J, Diaz-Marin C, et al. (2002) [A control and case study of multiple sclerosis in the Alicante and Villajoyosa areas]. Rev Neurol 34: 1013-1016.
32. Senecal-Quevillon M, Duquette P, Richer CL (1986) Analysis of sisterchromatid exchanges (SCEs) in familial and sporadic multiple sclerosis. Mutat Res 161: 65-74.
33. Turner AP, Kivlahan DR, Kazis LE, Haselkorn JK (2007) Smoking among veterans with multiple sclerosis: prevalence correlates, quit attempts, and unmet need for services. Arch Phys Med Rehabil 88: 1394-1399.
34. Munger KL, Peeling RW, Hernan MA, Chasan-Taber L, Olek MJ, et al. (2003) Infection with Chlamydia pneumoniae and risk of multiple sclerosis. Epidemiology 14: 141-147.
35. Munger KL, Chitnis T, Ascherio A (2009) Body size and risk of MS in two cohorts of US women. Neurology 73: 1543-1550.
36. Nortvedt MW, Riise T, Maeland JG (2005) Multiple sclerosis and lifestyle factors: the Hordaland Health Study. Neurol Sci 26: 334-339.
37. Villard-Mackintosh L, Vessey MP (1993) Oral contraceptives and reproductive factors in multiple sclerosis incidence. Contraception 47: 161-168.
38. Hill AB (1965) The Environment and Disease: Association or Causation? Proc R Soc Med 58: 295-300.
39. Sundstrom P, Nystrom L, Hallmans G (2008) Smoke exposure increases the risk for multiple sclerosis. Eur J Neurol 15: 579-583.
40. Smith KJ, Kapoor R, Felts PA (1999) Demyelination: the role of reactive oxygen and nitrogen species. Brain Pathol 9: 69-92.
41. Scolding N, Franklin R (1998) Axon loss in multiple sclerosis. Lancet 352: 340-341.
42. George J, Levy Y, Shoenfeld Y (1997) Smoking and immunity: an additional player in the mosaic of autoimmunity. Scand J Immunol 45: 1-6.
43. Green RM, Gally F, Keeney JG, Alper S, Gao B, et al. (2009) Impact of cigarette smoke exposure on innate immunity: a Caenorhabditis elegans model. PLoS ONE 4: e6860.
44. Fusby JS, Kassmeier MD, Palmer VL, Perry GA, Anderson DK, et al. (2010) Cigarette smoke-induced effects on bone marrow B-cell subsets and CD4+:CD8+ T-cell ratios are reversed by smoking cessation: influence of bone mass on immune cell response to and recovery from smoke exposure. Inhal Toxicol 22: 785-796.
45. Motz GT, Eppert BL, Wortham BW, Amos-Kroohs RM, Flury JL, et al. (2010) Chronic cigarette smoke exposure primes NK cell activation in a mouse model of chronic obstructive pulmonary disease. J Immunol 184: 4460-4469.
46. Mahdi H, Fisher BA, Kallberg H, Plant D, Malmstrom V, et al. (2009) Specific interaction between genotype, smoking and autoimmunity to citrullinated alphaenolase in the etiology of rheumatoid arthritis. Nat Genet 41: 1319-1324.
47. Graham NM (1990) The epidemiology of acute respiratory infections in children and adults: a global perspective. Epidemiol Rev 12: 149-178.
48. Tremlett H, van der Mei IA, Pittas F, Blizzard L, Paley G, et al. (2008) Monthly ambient sunlight, infections and relapse rates in multiple sclerosis. Neuroepidemiology 31: 271-279.
49. Lundstrom E, Kallberg H, Alfredsson L, Klareskog L, Padyukov L (2009) eneenvironment interaction between the DRB1 shared epitope and smoking in the risk of anti-citrullinated protein antibody-positive rheumatoid arthritis: all alleles are important. Arthritis Rheum 60: 1597-1603.
50. Mack WP, Stasior GO, Cao HJ, Stasior OG, Smith TJ (1999) The effect of cigarette smoke constituents on the expression of HLA-DR in orbital fibroblasts derived from patients with Graves ophthalmopathy. Ophthal Plast Reconstr Surg 15: 260-271.
51. Orton S-M, Herrera BM, Yee IM, Valdar W, Ramagopalan SV, et al. (2006) Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurology 5: 932-936.
52. Ascherio A, Munger KL (2007) Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol 61: 504-513.